SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-237638
Filing Date
2020-09-02
Accepted
2020-09-02 07:51:34
Documents
18
Period of Report
2020-08-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d944148d8k.htm   iXBRL 8-K 38899
2 EX-10.1 d944148dex101.htm EX-10.1 97514
3 EX-10.2 d944148dex102.htm EX-10.2 16285
4 EX-10.3 d944148dex103.htm EX-10.3 26924
5 EX-10.4 d944148dex104.htm EX-10.4 45048
6 EX-99.1 d944148dex991.htm EX-99.1 23901
10 GRAPHIC g944148g0901015813350.jpg GRAPHIC 4594
  Complete submission text file 0001193125-20-237638.txt   451439

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20200831.xsd EX-101.SCH 3104
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20200831_lab.xml EX-101.LAB 18137
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20200831_pre.xml EX-101.PRE 11430
11 EXTRACTED XBRL INSTANCE DOCUMENT d944148d8k_htm.xml XML 3471
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 201155688
SIC: 2834 Pharmaceutical Preparations